HomeSearchEuropean Neuropsychopharmacology

European Neuropsychopharmacology

Elsevier B.V. · Netherlands · Est. 1990

ISSN1873-7862
SJR Q1WOS SCIEScopus / SJR
60
/ 100
Medium Risk
Score Breakdown
WoS SCIE/SSCI+25
Scopus Q1+25
Total60
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
SJR Score
1.934
H-Index
156
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIP
1.34
Total Works
35,290
Total Citations
186,414
2yr Mean Citedness
1.00
Free JIF alternative
Retractions
1
Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal publishes research on neuropsychopharmacology, including the evaluation of digital mental health tools, the integrity of blinding in psychedelic research, the association between antidepressant use and colorectal cancer risk, reasons for dropout in antipsychotic trials for schizophrenia, the prevalence and treatment patterns of treatment-resistant depression, and the influence of gene-environment correlations on the neurobiology of major depressive disorder.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Q1
SJR Rank
Top 25% in field

General Information

Country / RegionNetherlands
Primary LanguageEnglish
1st Year Published1990
Frequency6 No. A Year, 1999-
StatusActive (last: 2026)
Total Publications35,290
Publisher OrgElsevier BV
Visit Journal Website

Submission Info

Peer Review
Review Time
Acceptance Rate
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/12 · 50%
Do you know the journal / publisher?
Elsevier B.V.
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1873-7862
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Biological PsychiatryQ1
NeurologyQ1
Neurology (clinical)Q1
PharmacologyQ1
Pharmacology (medical)Q1
Psychiatry and Mental HealthQ1

Subject Classification

Web of Science Categories

Clinical NeurologyNeurosciencesPharmacology & PharmacyPsychiatry

Scopus Categories

PharmacologyPharmacology (medical)Neurology (clinical)Biological PsychiatryPsychiatry and Mental HealthNeurology

Research Topics (OpenAlex)

Schizophrenia research and treatmentTreatment of Major DepressionBipolar Disorder and TreatmentTryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchStress Responses and CortisolAttention Deficit Hyperactivity DisorderFunctional Brain Connectivity StudiesReceptor Mechanisms and Signaling
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref